Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle

Rodney Taylor, KJ Drummond, G Salkeld, SD Sullivan

Research output: Contribution to journal › Article

154 Citations (Scopus)

Access to Document

@article{d378c86084e54b748477931809b5414f,

title = "Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle",

author = "Rodney Taylor and KJ Drummond and G Salkeld and SD Sullivan",

year = "2004",

month = dec,

day = "31",

doi = "10.1136/bmj.329.7472.972",

language = "English",

volume = "329",

pages = "972--975",

journal = "British Medical Journal",

issn = "1468-5833",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle

AU - Taylor, Rodney

AU - Drummond, KJ

AU - Salkeld, G

AU - Sullivan, SD

PY - 2004/12/31

Y1 - 2004/12/31

UR - http://www.scopus.com/inward/record.url?scp=6944244438&partnerID=8YFLogxK

U2 - 10.1136/bmj.329.7472.972

DO - 10.1136/bmj.329.7472.972

M3 - Article

C2 - 15499118

SN - 1468-5833

SN - 1756-1833

VL - 329

SP - 972

EP - 975

JO - British Medical Journal

JF - British Medical Journal

ER -